Quanticate, a global data-focused clinical research organization (CRO), is further expanding its service offering into India with the opening of a new office.

Located in Bangalore, the new office will be a base from which Quanticate will broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.

The decision to open the office follows a successful year for Quanticate, which saw an increase in sales driving the demand for more resources both in India and further afield. The new 16,500 square foot premises doubles the company’s current footprint in the country.

Praveen Dass, vice president of clinical data management and head of Indian operations at Quanticate, said, “By expanding our presence in India, we are able to increase our capacity meaning we can cater for more clients on a larger scale. We have an ambitious growth strategy to deliver over the next five years, which aims to employ over 60 new members of staff in the coming months. Our new office provides the perfect platform for this growth and marks an important milestone in our journey.”

As the company’s new operational center of excellence, the facility will also help Quanticate to provide customer service for its global client base and support further development of collaborative, long-term partnerships with leading pharmaceutical companies.